Sub-Themes
_______
The emergence and persistence of public health threats (infectious diseases, vector-borne diseases, zoonoses, antimicrobial resistance, environmental pollution, etc.) call into question the need to develop innovative and sustainable solutions based on the principles of the One Health approach. . Indeed, One Health is a collaborative, multi-sectoral and transdisciplinary approach working at local, regional, national and global levels to achieve optimal health (and well-being) outcomes by recognizing the interconnections between people, animals, the plants and the environment they share. This involves taking into account, for example, biodiversity, the dynamics of animal reservoirs, anthropogenic pressure, socio-cultural realities in the development of public health strategies and interventions, diagnosis, prevention and management. disease control. This sub-theme will take into account the following aspects:
*Epidemiology and fight against diseases with epidemic potential and zoonoses;
*Epidemiology and control of vector-borne diseases;
*Biotechnologies and innovative vector control methods;
*Early diagnosis and rapid response in preventing the spread of infectious diseases;
*social sciences for disease control.
The emergence and persistence of public health threats (infectious diseases, vector-borne diseases, zoonoses, antimicrobial resistance, environmental pollution, etc.) call into question the need to develop innovative and sustainable solutions based on the principles of the One Health approach. . Indeed, One Health is a collaborative, multi-sectoral and transdisciplinary approach working at local, regional, national and global levels to achieve optimal health (and well-being) outcomes by recognizing the interconnections between people, animals, the plants and the environment they share. This involves taking into account, for example, biodiversity, the dynamics of animal reservoirs, anthropogenic pressure, socio-cultural realities in the development of public health strategies and interventions, diagnosis, prevention and management. disease control. This sub-theme will take into account the following aspects:
*Epidemiology and fight against diseases with epidemic potential and zoonoses;
*Epidemiology and control of vector-borne diseases;
*Biotechnologies and innovative vector control methods;
*Early diagnosis and rapid response in preventing the spread of infectious diseases;
*social sciences for disease control.
Traditional medicine is one of the areas par excellence of endogenous knowledge and constitutes an important part of health care in many regions of the world including sub-Saharan Africa. For millions of people, particularly those living in remote and rural areas, and facing health, security and humanitarian challenges, it remains the first choice for health and well-being, providing culturally acceptable care, available and affordable. For populations in underdeveloped countries, it is generating a real revival of interest. However, one of the major challenges facing traditional medicine remains the need to have scientific data to inform policies on practices, standards and international regulations in order to guarantee safety, quality and equitable access. Through the sub-theme “Endogenous knowledge in health and development of phytomedicines”, JSI_2024 intends to stimulate discussions on the results of ongoing research in the development of human and veterinary phytomedicines in order to respond to the major challenges of accessibility to medicines. in a context of population resilience in the face of multiple crises. It is mainly expected to produce research results on ethnobotany, phytochemistry, biological properties of medicinal plants and other raw materials for traditional medicines, galenics and sociology, etc…
Traditional medicine is one of the areas par excellence of endogenous knowledge and constitutes an important part of health care in many regions of the world including sub-Saharan Africa. For millions of people, particularly those living in remote and rural areas, and facing health, security and humanitarian challenges, it remains the first choice for health and well-being, providing culturally acceptable care, available and affordable. For populations in underdeveloped countries, it is generating a real revival of interest. However, one of the major challenges facing traditional medicine remains the need to have scientific data to inform policies on practices, standards and international regulations in order to guarantee safety, quality and equitable access. Through the sub-theme “Endogenous knowledge in health and development of phytomedicines”, JSI_2024 intends to stimulate discussions on the results of ongoing research in the development of human and veterinary phytomedicines in order to respond to the major challenges of accessibility to medicines. in a context of population resilience in the face of multiple crises. It is mainly expected to produce research results on ethnobotany, phytochemistry, biological properties of medicinal plants and other raw materials for traditional medicines, galenics and sociology, etc…
Caring for people with illnesses remains the cornerstone of medicine. To do this, the search for new drugs, new preventive molecules and diagnostic tools have always been prerequisites for health care. In a context of emergence of new infectious agents and/or destabilization of health systems, it is essential to strengthen research and development of drugs, phytomedicines and vaccines to face the challenges of medical care of populations. This sub-theme should allow research stakeholders to share the latest innovations and those to come in the following areas: development of new drugs, phytomedicines, therapeutic and diagnostic tools, vaccines, but also strategies for individual or collective intervention for disease management.
Caring for people with illnesses remains the cornerstone of medicine. To do this, the search for new drugs, new preventive molecules and diagnostic tools have always been prerequisites for health care. In a context of emergence of new infectious agents and/or destabilization of health systems, it is essential to strengthen research and development of drugs, phytomedicines and vaccines to face the challenges of medical care of populations. This sub-theme should allow research stakeholders to share the latest innovations and those to come in the following areas: development of new drugs, phytomedicines, therapeutic and diagnostic tools, vaccines, but also strategies for individual or collective intervention for disease management.
For more than a decade, many sub-Saharan countries have been facing an unprecedented security crisis. This crisis has repercussions on the health system. Indeed, a restriction of access to basic health services with the closure of several health facilities was observed in areas with a high security challenge. Furthermore, in 2020, the COVID-19 pandemic weakened already suffering health systems. Climate change and many other social, economic and political changes then pose the challenge of the capacity of these health systems to withstand and respond effectively to shocks, in order to maintain access and continuity of basic health services. to populations and in particular to the most vulnerable such as women, children and internally displaced people. Thus, it is important to share experiences in the provision of reproductive, maternal and child health services in a context of resilience to establish evidence capable of improving the well-being of the most vulnerable populations. more vulnerable.
Traditional medicine is one of the areas par excellence of endogenous knowledge and constitutes an important part of health care in many regions of the world including sub-Saharan Africa. For millions of people, particularly those living in remote and rural areas, and facing health, security and humanitarian challenges, it remains the first choice for health and well-being, providing culturally acceptable care, available and affordable. For populations in underdeveloped countries, it is generating a real revival of interest. However, one of the major challenges facing traditional medicine remains the need to have scientific data to inform policies on practices, standards and international regulations in order to guarantee safety, quality and equitable access. Through the sub-theme “Endogenous knowledge in health and development of phytomedicines”, JSI_2024 intends to stimulate discussions on the results of ongoing research in the development of human and veterinary phytomedicines in order to respond to the major challenges of accessibility to medicines. in a context of population resilience in the face of multiple crises. It is mainly expected to produce research results on ethnobotany, phytochemistry, biological properties of medicinal plants and other raw materials for traditional medicines, galenics and sociology, etc…
Les maladies non transmissibles (MNT) sont reconnues comme un défi majeur pour le développement durable. Elles touchent les personnes de tous les groupes d’âge, régions et pays. L’émergence dans les pays d’Afrique au sud du Sahara, des maladies chroniques non transmissibles liées à la nutrition longtemps considérées comme maladies des pays industrialisés est aujourd’hui un fait, avec une vélocité et une mortalité plus grande due au maladies cardiovasculaires, suivies des cancers, des maladies respiratoires chroniques et du diabète. La malnutrition sous toutes ses formes et les facteurs environnementaux font partie des principaux facteurs de risque associés à ces affections dites maladies non transmissibles (cancer, diabète, drépanocytose, HTA, …) et/ ou génétiques ou épigénétiques. Les différentes crises que traversent le monde et la sous-région Ouest-africaine ainsi que les changements climatiques impactent négativement la sécurité alimentaire et nutritionnelle complexifiant davantage la recherche de solutions contre les problèmes de dénutrition et de carences nutritionnelles. Les travaux scientifiques sur cette question soulignent également le rôle des facteurs environnementaux comme l’exposition à la pollution de l’air, les pesticides et les produits de traitement miniers. Ils établissent à plus de 80 % la responsabilité de facteurs qui peuvent être prévenus. Ces journées seront l’occasion de faire le point des avancées significatives de la recherche sur la pollution environnementale et pathologies chroniques, carences nutritionnelles/épidémiologie nutritionnelle, nutrigénomique et maladies non transmissibles (cancer, diabète, drépanocytose, HTA, …) et/ ou génétiques ou épigénétiques.
Les maladies non transmissibles (MNT) sont reconnues comme un défi majeur pour le développement durable. Elles touchent les personnes de tous les groupes d’âge, régions et pays. L’émergence dans les pays d’Afrique au sud du Sahara, des maladies chroniques non transmissibles liées à la nutrition longtemps considérées comme maladies des pays industrialisés est aujourd’hui un fait, avec une vélocité et une mortalité plus grande due au maladies cardiovasculaires, suivies des cancers, des maladies respiratoires chroniques et du diabète. La malnutrition sous toutes ses formes et les facteurs environnementaux font partie des principaux facteurs de risque associés à ces affections dites maladies non transmissibles (cancer, diabète, drépanocytose, HTA, …) et/ ou génétiques ou épigénétiques. Les différentes crises que traversent le monde et la sous-région Ouest-africaine ainsi que les changements climatiques impactent négativement la sécurité alimentaire et nutritionnelle complexifiant davantage la recherche de solutions contre les problèmes de dénutrition et de carences nutritionnelles. Les travaux scientifiques sur cette question soulignent également le rôle des facteurs environnementaux comme l’exposition à la pollution de l’air, les pesticides et les produits de traitement miniers. Ils établissent à plus de 80 % la responsabilité de facteurs qui peuvent être prévenus. Ces journées seront l’occasion de faire le point des avancées significatives de la recherche sur la pollution environnementale et pathologies chroniques, carences nutritionnelles/épidémiologie nutritionnelle, nutrigénomique et maladies non transmissibles (cancer, diabète, drépanocytose, HTA, …) et/ ou génétiques ou épigénétiques.
Open topics are accepted
Open topics are accepted
The emergence and persistence of public health threats (infectious diseases, vector-borne diseases, zoonoses, antimicrobial resistance, environmental pollution, etc.) call into question the need to develop innovative and sustainable solutions based on the principles of the One Health approach. . Indeed, One Health is a collaborative, multi-sectoral and transdisciplinary approach working at local, regional, national and global levels to achieve optimal health (and well-being) outcomes by recognizing the interconnections between people, animals, the plants and the environment they share. This involves taking into account, for example, biodiversity, the dynamics of animal reservoirs, anthropogenic pressure, socio-cultural realities in the development of public health strategies and interventions, diagnosis, prevention and management. disease control. This sub-theme will take into account the following aspects:
*Epidemiology and fight against diseases with epidemic potential and zoonoses;
*Epidemiology and control of vector-borne diseases;
*Biotechnologies and innovative vector control methods;
*Early diagnosis and rapid response in preventing the spread of infectious diseases;
*social sciences for disease control.
Traditional medicine is one of the areas par excellence of endogenous knowledge and constitutes an important part of health care in many regions of the world including sub-Saharan Africa. For millions of people, particularly those living in remote and rural areas, and facing health, security and humanitarian challenges, it remains the first choice for health and well-being, providing culturally acceptable care, available and affordable. For populations in underdeveloped countries, it is generating a real revival of interest. However, one of the major challenges facing traditional medicine remains the need to have scientific data to inform policies on practices, standards and international regulations in order to guarantee safety, quality and equitable access. Through the sub-theme “Endogenous knowledge in health and development of phytomedicines”, JSI_2024 intends to stimulate discussions on the results of ongoing research in the development of human and veterinary phytomedicines in order to respond to the major challenges of accessibility to medicines. in a context of population resilience in the face of multiple crises. It is mainly expected to produce research results on ethnobotany, phytochemistry, biological properties of medicinal plants and other raw materials for traditional medicines, galenics and sociology, etc…
Caring for people with illnesses remains the cornerstone of medicine. To do this, the search for new drugs, new preventive molecules and diagnostic tools have always been prerequisites for health care. In a context of emergence of new infectious agents and/or destabilization of health systems, it is essential to strengthen research and development of drugs, phytomedicines and vaccines to face the challenges of medical care of populations. This sub-theme should allow research stakeholders to share the latest innovations and those to come in the following areas: development of new drugs, phytomedicines, therapeutic and diagnostic tools, vaccines, but also strategies for individual or collective intervention for disease management.
For more than a decade, many sub-Saharan countries have been facing an unprecedented security crisis. This crisis has repercussions on the health system. Indeed, a restriction of access to basic health services with the closure of several health facilities was observed in areas with a high security challenge. Furthermore, in 2020, the COVID-19 pandemic weakened already suffering health systems. Climate change and many other social, economic and political changes then pose the challenge of the capacity of these health systems to withstand and respond effectively to shocks, in order to maintain access and continuity of basic health services. to populations and in particular to the most vulnerable such as women, children and internally displaced people. Thus, it is important to share experiences in the provision of reproductive, maternal and child health services in a context of resilience to establish evidence capable of improving the well-being of the most vulnerable populations. more vulnerable.
Les maladies non transmissibles (MNT) sont reconnues comme un défi majeur pour le développement durable. Elles touchent les personnes de tous les groupes d’âge, régions et pays. L’émergence dans les pays d’Afrique au sud du Sahara, des maladies chroniques non transmissibles liées à la nutrition longtemps considérées comme maladies des pays industrialisés est aujourd’hui un fait, avec une vélocité et une mortalité plus grande due au maladies cardiovasculaires, suivies des cancers, des maladies respiratoires chroniques et du diabète. La malnutrition sous toutes ses formes et les facteurs environnementaux font partie des principaux facteurs de risque associés à ces affections dites maladies non transmissibles (cancer, diabète, drépanocytose, HTA, …) et/ ou génétiques ou épigénétiques. Les différentes crises que traversent le monde et la sous-région Ouest-africaine ainsi que les changements climatiques impactent négativement la sécurité alimentaire et nutritionnelle complexifiant davantage la recherche de solutions contre les problèmes de dénutrition et de carences nutritionnelles. Les travaux scientifiques sur cette question soulignent également le rôle des facteurs environnementaux comme l’exposition à la pollution de l’air, les pesticides et les produits de traitement miniers. Ils établissent à plus de 80 % la responsabilité de facteurs qui peuvent être prévenus. Ces journées seront l’occasion de faire le point des avancées significatives de la recherche sur la pollution environnementale et pathologies chroniques, carences nutritionnelles/épidémiologie nutritionnelle, nutrigénomique et maladies non transmissibles (cancer, diabète, drépanocytose, HTA, …) et/ ou génétiques ou épigénétiques.
Open topics are accepted
Abstract submission link
Warning : Only use this link submit yours abstracts, If you submit it anywhere else it will not be accepted